Explore more publications!
Niue Health Report
Submit Press Release

Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 22, 2025

OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
September 22, 2025

OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain

Indeterminate GlobeNewswire
FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. ACQUISITION
September 22, 2025

FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. ACQUISITION

Indeterminate GlobeNewswire
AMN Healthcare Launches $400.0 Million Offering of Senior Notes
September 22, 2025

AMN Healthcare Launches $400.0 Million Offering of Senior Notes

Indeterminate GlobeNewswire
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
September 22, 2025

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

Indeterminate GlobeNewswire
Medtech Leader Erica Rogers Joins Ceribell Board of Directors
September 22, 2025

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

Indeterminate GlobeNewswire
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
September 22, 2025

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Indeterminate GlobeNewswire
Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research
September 22, 2025

Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research

Indeterminate GlobeNewswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc.
September 22, 2025

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Vuong Trieu, CEO of Oncotelic Therapeutics Inc.

Indeterminate GlobeNewswire
Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders
September 22, 2025

Cerevance to Present Phase 2 Data on Solengepras in Parkinson’s Disease at the 2025 International Congress of Parkinson's Disease and Movement Disorders

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
September 22, 2025

Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025

Indeterminate GlobeNewswire
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
September 22, 2025

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Indeterminate GlobeNewswire
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
September 22, 2025

electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards

Indeterminate GlobeNewswire
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
September 22, 2025

Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)

Indeterminate GlobeNewswire
First-Ever EHR-Linked Devices Supercharge Timelier, Personalized Care
September 22, 2025

First-Ever EHR-Linked Devices Supercharge Timelier, Personalized Care

Indeterminate GlobeNewswire
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
September 22, 2025

ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study

Indeterminate GlobeNewswire
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
September 22, 2025

Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation

Indeterminate GlobeNewswire
BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
September 22, 2025

BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure

Indeterminate GlobeNewswire
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
September 22, 2025

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting

Indeterminate GlobeNewswire
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
September 22, 2025

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)

Indeterminate GlobeNewswire
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
September 22, 2025

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions